Business
TSX Venture Exchange, Satellos Bioscience Inc., View From The C-Suite
TSX Venture Exchange, Satellos Bioscience Inc., View From The C-Suite Canada NewsWire ...
About this update from Satellos Bioscience Inc
[{"type":"text","content":"\n \n \n \n TSX Venture Exchange, Satellos Bioscience Inc., View From The C-Suite\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n \n ,\n \n \n Aug. 21, 2023\n \n \n /CNW/ - Frank Gleeson, Chief Executive Officer, Satellos Bioscine (TSXV: MSCL) (\"Satellos\" or the \"Company\") shares his Company's story in an\n \n \n interview\n \n \n with TMX Group.\n \n \n \n \n \n \n \n \n The View From The C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To see the latest View From The C-Suite visit\n \n https://www.tmxmoney.com/en/csuite.html\n \n .\n \n \n \n \n About Satellos Bioscience Inc. (TSXV: MSCL)\n \n \n \n \n Satellos is a biotechnology company dedicated to developing lifechanging medicines to treat degenerative muscle conditions.\n \n \n CNW sponsored announcement. To learn more visit\n \n www.newswire.ca\n \n .\n \n \n \n \n \n View original content to download multimedia:\n \n https://www.prnewswire.com/news-releases/tsx-venture-exchange-satellos-bioscience-inc-view-from-the-c-suite-301905913.html\n \n \n \n SOURCE TSX Venture Exchange\n \n \n \n \n \n \n View original content to download multimedia:\n \n http://www.newswire.ca/en/releases/archive/August2023/21/c4705.html\n \n \n \n \n\n","length":4378,"tagName":"div"}]